Re:: Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years

被引：0
|
作者：
Sun, L. [1 ]
Moul, J. W. [1 ]
Hotaling, J. M. [1 ]
Rampersaud, E. [1 ]
Dahm, P. [1 ]
Robertson, C. [1 ]
Fitzsimons, N. [1 ]
Albala, D. [1 ]
Polascik, T. J. [1 ]
机构：
[1] Erasmus MC, Univ Med Ctr, Dept Urol, Rotterdam, Netherlands
来源：
EUROPEAN UROLOGY | 2007年 / 52卷 / 03期
关键词：
D O I：
10.1016/j.eururo.2007.06.014
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：921 / 921
页数：1
相关论文
共 50 条
  • [1] Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years
    Sun, Leon
    Moul, Judd W.
    Hotaling, James M.
    Rampersaud, Edward
    Dahm, Phillipp
    Robertson, Cary
    Fitzsimons, Nicholas
    Albala, David
    Polascik, Thomas J.
    [J]. BJU INTERNATIONAL, 2007, 99 (04) : 753 - 757
  • [2] Prostate-specific antigen (PSA) and PSA density: Racial differences in men without prostate cancer
    Henderson, RJ
    Eastham, JA
    Culkin, DJ
    Kattan, MW
    Whatley, T
    Mata, J
    Venable, D
    Sartor, O
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (02) : 134 - 138
  • [3] Prostate-specific antigen velocity and prostate-specific antigen slope compared for prostate cancer diagnosis in men with 3 or more PSA measurements
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 239 - 239
  • [4] Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time
    Ng, Michael K.
    Van As, Nicholas
    Thomas, Karen
    Woode-Amissah, Ruth
    Horwich, Alan
    Huddart, Robert
    Khoo, Vincent
    Thompson, Alan
    Dearnaley, David
    Parker, Chris
    [J]. BJU INTERNATIONAL, 2009, 103 (07) : 872 - 876
  • [5] Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook
    Gielchinsky, Ilan
    Chang, John
    Cusick, Thomas
    Delprado, Warick
    Quoc Nguyen
    Yuen, Carlo
    Savdie, Richard
    Bohm, Maret
    Haynes, Anne-Maree
    Scheltema, Matthijs J.
    Stricker, Phillip D.
    [J]. BJU INTERNATIONAL, 2018, 122 : 35 - 41
  • [6] PROSTATE-SPECIFIC ANTIGEN (PSA)
    HOWANITZ, JH
    [J]. DISEASE MARKERS, 1993, 11 (01) : 3 - 10
  • [7] Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL
    Hong, Sung Kyu
    Oh, Jong Jin
    Byun, Seok-Soo
    Hwang, Sung Il
    Choo, Min Soo
    Lee, Sang Eun
    [J]. BJU INTERNATIONAL, 2012, 110 (2B) : E81 - E85
  • [8] PROSTATE-SPECIFIC ANTIGEN (PSA) LEVELS IN MEN <60 YEARS OF AGE PREDICTS LETHAL PROSTATE CANCER
    Preston, Mark A.
    Batista, Julie
    Carlsson, Sigrid
    Gerke, Travis
    Dahl, Douglas M.
    Feldman, Adam S.
    Gann, Peter H.
    Vickers, Andrew
    Stampfer, Meir J.
    Mucci, Lorelei A.
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E816 - E816
  • [9] Prostate-specific antigen (PSA) and PSA velocity: Competitors or collaborators in the prediction of curable and clinically significant prostate cancer
    D'Amico, Anthony V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 823 - 824
  • [10] Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer
    Tello, FL
    Prats, CH
    González, MDD
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (02) : 116 - 120
12345